27
Participants
Start Date
May 31, 1999
Primary Completion Date
April 30, 2005
Study Completion Date
April 30, 2005
Thalidomide
200 mg at bedtime daily for 14 days (days 1-14), followed by an increase to 400 mg daily for 14 days (days 15-28), 600 mg daily for 14 days (days 29-42), up to a maximum 800 mg (days 43-completion)
University of Texas M. D. Anderson Cancer Center, Houston
Collaborators (1)
Celgene Corporation
INDUSTRY
M.D. Anderson Cancer Center
OTHER